IRIS
ARNALDI, DARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.798
Totale 9.798
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 9.798
Totale 9.798
Salva come PNG Salva come JPEG
Città #
Genova 7.240
Rapallo 1.466
Genoa 1.033
Bordighera 59
Totale 9.798
Salva come PNG Salva come JPEG
Nome #
Visual Versus Semi-Quantitative Analysis of 18F-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) Project. 159
Brain 18F-DOPA PET and cognition in de novo Parkinson's disease. 140
A normative study of the Italian printed word version of the free and cued selective reminding test 140
Alzheimer’s disease markers from structural MRI and FDG-PET brain images 138
Brain Functional Network in Alzheimer’s Disease: Diagnostic Markers for Diagnosis and Monitoring 130
Assessment of cognitive profile as a prodromal marker of the evolution of REM sleep Behavior Disorder 127
Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD). 126
Neuroimaging findings in mild cognitive impairment 123
How legislation on decisional capacity can negatively affect the feasibility of clinical trials in patients with dementia. 122
Analysis of video-polysomnographic sleep findings in dementia with Lewy bodies. 121
Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson's disease. 121
Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease 116
Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers 114
Nigro-caudate dopaminergic deafferentation: A marker of REM sleep behavior disorder? 113
What predicts cognitive decline in de novo Parkinson's disease? 113
Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson's disease and probable RBD 113
Brain perfusion SPECT provides new insight on neurobiological effects of hyperbaric hyperoxia. 111
Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT SPECT study. 109
Does postural rigidity decrease during REM sleep without Atonia in Parkinson disease? 108
Volume of interest-based [(18)F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study. 107
Striatal dopamine transporter SPECT quantification: head-to-head comparison between two three-dimensional automatic tools 107
Correlation between Doppler velocities and duplex ultrasound carotid cross-sectional percent stenosis. 106
The role of the serotonergic system in REM sleep behavior disorder 106
Mapping brain morphological and functional conversion patterns in predementia late-onset bvFTD 106
Parkinson’s Disease Sleep Scale 2: application in an Italian population 106
Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 106
Neuroimaging features in C9orf72 and TARDBP double mutation with FTD phenotype. 105
Seizures can precede cognitive symptoms in late-onset Alzheimer's disease. 104
Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints. 104
The Alzheimer's disease metabolic brain pattern in mild cognitive impairment 102
The clinical relevance of cognitive impairment in REM sleep behavior disorder 101
Integrating Sleep and Alzheimer's Disease Pathophysiology: Hints for Sleep Disorders Management 101
Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease 101
Early identification of MCI converting to AD: a FDG PET study 100
Idiopathic REM sleep behavior disorder and neurodegenerative risk: To tell or not to tell to the patient? How to minimize the risk? 100
Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases 100
Abnormalities of resting-state functional cortical connectivity in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 99
Cortical Network Topology in Prodromal and Mild Dementia Due to Alzheimer’s Disease: Graph Theory Applied to Resting State EEG 99
New tracers and new perspectives for molecular imaging in Lewy body diseases 99
Seven tesla MRI of the substantia nigra in patients with rapid eye movement sleep behavior disorder 95
Frontal Variant Alzheimer Disease or Frontotemporal Lobe Degeneration With Incidental Amyloidosis? 94
Loss of REM sleep features across nighttime in REM sleep behavior disorder 94
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study 93
Presynaptic dopaminergic neuroimaging in REM sleep behavior disorder: A systematic review and meta-analysis 92
Functional imaging in pre-motor Parkinson's disease 90
Functional cortical source connectivity of resting state electroencephalographic alpha rhythms shows similar abnormalities in patients with mild cognitive impairment due to Alzheimer's and Parkinson's diseases 90
Progressive disgregation of brain networking from normal aging to Alzhimer's Disease. Independent Component Analysis on FDG-PET data 89
Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI 87
The influence of nigrostriatal dopaminergic dysfunction on cognition of de novo Parkinson's disease patients 86
Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder 86
Abnormalities of functional cortical source connectivity of resting-state electroencephalographic alpha rhythms are similar in patients with mild cognitive impairment due to Alzheimer's and Lewy body diseases 85
Abnormal pattern of brain glucose metabolism in Parkinson's disease: replication in three European cohorts 84
The prognostic value of sleep patterns in disorders of consciousness in the sub-acute phase 83
Brain glucose metabolism heterogeneity in idiopathic REM sleep behavior disorder and in Parkinson's disease 83
What predicts future cognitive decline in de novo Parkinson’s disease (PD)? 82
The pharmacotherapeutic management of obstructive sleep apnea 82
Neurophysiological Assessment of Alzheimer's Disease Individuals by a Single Electroencephalographic Marker 81
Metabolic patterns across core features in dementia with lewy bodies 81
Direct correlation between cardiac and striatal F-18-DOPA uptake in de novo Parkinson's disease 80
Is dopamine transporter invariably impaired at the time of diagnosis in dementia with Lewy bodies? 80
The fate of patients with REM sleep behavior disorder and Mild Cognitive Impairment 80
Metabolic correlates of rey auditory verbal learning test in elderly subjects with memory complaints 80
A kinetics-based approach to amyloid PET semi-quantification 79
Levodopa may affect cortical excitability in Parkinson's disease patients with cognitive deficits as revealed by reduced activity of cortical sources of resting state electroencephalographic rhythms 79
Predicting the transition from normal aging to Alzheimer's disease: A statistical mechanistic evaluation of FDG-PET data 77
Brain dopaminergic correlates of cognitive functions in de novo parkinson’s disease: a 18FDOPA PET study. 75
Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study 74
Getting the high school diploma with only one hemisphere: a case report 73
Abnormalities of resting-state EEG in patients with prodromal and overt dementia with Lewy bodies: Relation to clinical symptoms 73
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease 73
Performance of [18F] FDG-PET in 142 MCI patients with at least 2 years clinical follow up: a multicentric study of the European Alzheimer Disease Consortium (EADC) 72
18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage 72
Recommendations of the Sleep Study Group of the Italian Dementia Research Association (SINDem) on clinical assessment and management of sleep disorders in individuals with mild cognitive impairment and dementia: a clinical review. 71
Comparative study of MRI biomarkers in the substantia nigra to discriminate idiopathic Parkinson disease 71
Metabolic correlates of dopaminergic loss in dementia with lewy bodies 71
Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD) 71
null 70
Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD) Rik Ossenkoppele 69
Scaled Subprofile Modeling and Convolutional Neural Networks for the Identification of Parkinson's Disease in 3D Nuclear Imaging Data 69
123I-FP-CIT SPECT validation of nigro-putaminal MRI tractography in dementia with Lewy bodies 69
null 67
Cognitive impairment in degenerative parkinsonisms: role of radionuclide brain imaging. 67
null 66
Neuroimaging Findings in Mild Cognitive Impairment 64
Abnormalities of Cortical Sources of Resting State Alpha Electroencephalographic Rhythms are Related to Education Attainment in Cognitively Unimpaired Seniors and Patients with Alzheimer's Disease and Amnesic Mild Cognitive Impairment 64
Dopaminergic Activity and Cognitive Function in de novo Parkinson Disease patients: an 18F-DOPA PET/CT study 63
Lupus nephritis and Cyclic Vomiting Syndrome: a case report. 63
The role of anterior prefrontal cortex in prospective memory: an exploratory FDG-PET study in early Alzheimer's disease 62
Resting metabolic connectivity in Alzheimer's disease 59
Hyperconnectivity in Dementia Is Early and Focal and Wanes with Progression 59
Associations among education, age, and the dementia with Lewy bodies (DLB) metabolic pattern: A European-DLB consortium project 59
Metabolic network abnormalities in drug-naïve Parkinson's Disease 56
Abnormal cortical neural synchronization mechanisms in quiet wakefulness are related to motor deficits, cognitive symptoms, and visual hallucinations in Parkinson's disease patients: an electroencephalographic study 56
Anatomical and neurochemical bases of theory of mind in de novo Parkinson's Disease 56
Utility of quantitative EEG in early Lewy body disease 55
Nigrocaudate dopaminergic impairment predict future cognitive decline in de novo parkinson’s disease (PD) 55
Epilepsy course during COVID-19 pandemic in three Italian epilepsy centers 55
Multicenter Study on Sleep and Circadian Alterations as Objective Markers of Mild Cognitive Impairment and Alzheimer's Disease Reveals Sex Differences 54
Probing the Role of a Regional Quantitative Assessment of Amyloid PET 54
Neuroimaging of Rapid Eye Movement Sleep Behavior Disorder 53
Totale 8.875
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.157
article - articoli 32.927
book - libri 0
conference - conferenze 1.316
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 914
Totale 70.314
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019387 0 0 0 0 0 0 0 0 0 0 211 176
2019/20202.683 95 63 78 165 228 286 399 275 293 451 277 73
2020/20211.462 70 129 96 200 134 146 131 123 83 168 89 93
2021/20221.585 49 52 120 154 57 128 68 338 124 187 77 231
2022/20231.712 140 151 38 197 227 252 7 129 294 44 205 28
2023/2024923 65 96 25 172 91 197 88 81 58 44 6 0
Totale 10.187